Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 31906959)

  • 1. Effect of adjuvant chemotherapy on survival benefit in stage III colon cancer patients stratified by age: a Japanese real-world cohort study.
    Kawamura H; Morishima T; Sato A; Honda M; Miyashiro I
    BMC Cancer; 2020 Jan; 20(1):19. PubMed ID: 31906959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and survival benefit of adjuvant chemotherapy in stage III colon cancer patients: Comparison of overall and age-stratified results by multivariable modeling and propensity score methodology in a population-based cohort.
    Hines RB; Bimali M; Johnson AM; Bayakly AR; Collins TC
    Cancer Epidemiol; 2016 Oct; 44():77-83. PubMed ID: 27513721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer.
    Sanoff HK; Carpenter WR; Martin CF; Sargent DJ; Meyerhardt JA; Stürmer T; Fine JP; Weeks J; Niland J; Kahn KL; Schymura MJ; Schrag D
    J Natl Cancer Inst; 2012 Feb; 104(3):211-27. PubMed ID: 22266473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years.
    Sanoff HK; Carpenter WR; Stürmer T; Goldberg RM; Martin CF; Fine JP; McCleary NJ; Meyerhardt JA; Niland J; Kahn KL; Schymura MJ; Schrag D
    J Clin Oncol; 2012 Jul; 30(21):2624-34. PubMed ID: 22665536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer.
    Zuckerman IH; Rapp T; Onukwugha E; Davidoff A; Choti MA; Gardner J; Seal B; Mullins CD
    J Am Geriatr Soc; 2009 Aug; 57(8):1403-10. PubMed ID: 19563521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in Delayed Time to Adjuvant Chemotherapy and Disease-Specific Survival in Stage III Colon Cancer Patients.
    Becerra AZ; Aquina CT; Mohile SG; Tejani MA; Schymura MJ; Boscoe FP; Xu Z; Justiniano CF; Boodry CI; Swanger AA; Noyes K; Monson JR; Fleming FJ
    Ann Surg Oncol; 2017 Jun; 24(6):1610-1617. PubMed ID: 27738848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer.
    Casadaban L; Rauscher G; Aklilu M; Villenes D; Freels S; Maker AV
    Cancer; 2016 Nov; 122(21):3277-3287. PubMed ID: 27417445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of Oxaliplatin Doublet Adjuvant Chemotherapy in Elderly Patients With Stage III Colon Cancer.
    Brungs D; Aghmesheh M; de Souza P; Carolan M; Clingan P; Rose J; Ranson M
    Clin Colorectal Cancer; 2018 Sep; 17(3):e549-e555. PubMed ID: 29861156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemotherapy for stage II right-sided and left-sided colon cancer: analysis of SEER-medicare data.
    Weiss JM; Schumacher J; Allen GO; Neuman H; Lange EO; Loconte NK; Greenberg CC; Smith MA
    Ann Surg Oncol; 2014 Jun; 21(6):1781-91. PubMed ID: 24643898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy for stage II colon cancer with poor prognostic features.
    O'Connor ES; Greenblatt DY; LoConte NK; Gangnon RE; Liou JI; Heise CP; Smith MA
    J Clin Oncol; 2011 Sep; 29(25):3381-8. PubMed ID: 21788561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefit of Postresection Adjuvant Chemotherapy for Stage III Colon Cancer in Octogenarians: Analysis of the National Cancer Database.
    Bergquist JR; Thiels CA; Spindler BA; Shubert CR; Hayman AV; Kelley SR; Larson DW; Habermann EB; Pemberton JH; Mathis KL
    Dis Colon Rectum; 2016 Dec; 59(12):1142-1149. PubMed ID: 27824699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy for stage III colon cancer in the oldest old: results beyond clinical guidelines.
    Abraham A; Habermann EB; Rothenberger DA; Kwaan M; Weinberg AD; Parsons HM; Gupta P; Al-Refaie WB
    Cancer; 2013 Jan; 119(2):395-403. PubMed ID: 22806931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and toxicity of adjuvant chemotherapy in elderly patients with colon carcinoma: a 10-year experience of the Geisinger Medical Center.
    Fata F; Mirza A; Craig G; Nair S; Law A; Gallagher J; Ellison N; Bernath A
    Cancer; 2002 Apr; 94(7):1931-8. PubMed ID: 11932894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization and impact of adjuvant chemotherapy among patients with resected stage II colon cancer: a multi-institutional analysis.
    Ejaz A; Casadaban L; Maker AV
    J Surg Res; 2017 Jul; 215():12-20. PubMed ID: 28688636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction between BRAF mutation and microsatellite instability (MSI) status in determining survival outcomes after adjuvant 5FU based chemotherapy in stage III colon cancer.
    Chouhan H; Sammour T; Thomas ML; Moore JW
    J Surg Oncol; 2018 Dec; 118(8):1311-1317. PubMed ID: 30399198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilisation of Adjuvant Chemotherapy and 5-Year Survival Analysis of Prospectively Recorded Cohort Data for Older Adults Versus Younger Adults with Resected Primary Colon Cancer.
    Shafiei M; Beale P; Blinman P
    J Gastrointest Cancer; 2020 Sep; 51(3):988-997. PubMed ID: 31811472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of chemotherapy in older patients with stage II and III colon cancer: Variation by age and era of diagnosis.
    Green SL; Dawe DE; Nugent Z; Cheung WY; Czaykowski PM
    J Geriatr Oncol; 2019 Jan; 10(1):132-137. PubMed ID: 30104156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opportunity lost: Adjuvant chemotherapy in patients with stage III colon cancer remains underused.
    Becerra AZ; Probst CP; Tejani MA; Aquina CT; González MG; Hensley BJ; Noyes K; Monson JR; Fleming FJ
    Surgery; 2015 Sep; 158(3):692-9. PubMed ID: 26032822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effectiveness of different chemotherapeutic regimens on survival of people aged 66 and older with stage III colon cancer: a "real world" analysis using Surveillance, Epidemiology, and End Results-Medicare data.
    Hsiao FY; Mullins CD; Onukwugha E; Pandya N; Hanna N
    J Am Geriatr Soc; 2011 Sep; 59(9):1717-23. PubMed ID: 21831168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use and Effectiveness of Adjuvant Chemotherapy for Stage III Colon Cancer: A Population-Based Study.
    Booth CM; Nanji S; Wei X; Peng Y; Biagi JJ; Hanna TP; Krzyzanowska MK; Mackillop WJ
    J Natl Compr Canc Netw; 2016 Jan; 14(1):47-56. PubMed ID: 26733554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.